Theresa L Werner

Theresa L Werner

UNVERIFIED PROFILE

Are you Theresa L Werner?   Register this Author

Register author
Theresa L Werner

Theresa L Werner

Publications by authors named "Theresa L Werner"

Are you Theresa L Werner?   Register this Author

48Publications

1041Reads

30Profile Views

Do vaginal recurrence rates differ among adjuvant vaginal brachytherapy regimens in early-stage endometrial cancer?

Brachytherapy 2019 Jul - Aug;18(4):453-461. Epub 2019 Apr 17.

Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2019.03.001DOI Listing
January 2020

LVSI positive and NX in early endometrial cancer: Surgical restaging (and no further treatment if N0), or adjuvant ERT?

Gynecol Oncol 2020 01 5;156(1):243-250. Epub 2019 Nov 5.

Huntsman Cancer Institute, 2000 Circle of Hope Drive, Salt Lake City, UT, 84112, USA; Department of Radiation Oncology, University of Utah School of Medicine, 1950 Circle of Hope, Rm 1570, Salt Lake City, UT, 84112, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2019.09.016DOI Listing
January 2020

Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer.

N Engl J Med 2019 12 28;381(25):2403-2415. Epub 2019 Sep 28.

From the University of Texas M.D. Anderson Cancer Center, Houston (R.L.C.); University of Chicago Medicine (G.F.F.) and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University (D.C.), Chicago, and AbbVie, North Chicago (D.M.S., B.A.B., S.B., C.K.R., P.J.A., M.H.D.) - all in Illinois; NRG Oncology Statistical and Data Center, Roswell Park Cancer Institute, Buffalo (M.F.B.), and Memorial Sloan Kettering Cancer Center, New York (K.B.-M., C.A.) - both in New York; University of Washington-Seattle Cancer Care Alliance, Seattle (E.M.S.); Lillebaelt University Hospital of Southern Denmark, Vejle, and the University of Southern Denmark, Odense (K.D.S.); Prince of Wales Clinical School, University of New South Wales and Royal Hospital for Women (M.F.), and the Northern Cancer Institute (S.B.-H.), Sydney; Jikei University School of Medicine, Tokyo (A. Okamoto), and Aichi Cancer Center Hospital, Nagoya (M.M.) - both in Japan; Stephenson Cancer Center at the University of Oklahoma Health Sciences Center, Oklahoma City (K.N.M.); Kaplan Medical Center, Rehovot, Israel (N.E.B.-B.); Huntsman Cancer Institute, University of Utah, Salt Lake City (T.L.W.); Texas Oncology, U.S. Oncology Research Network, Fort Worth (N.G.C.); Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona (A. Oaknin); Women and Infants Hospital, Providence, RI (P.A.D.); Penn Medicine, Philadelphia (M.A.M.); University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea (J.-H.N.); O'Neal Comprehensive Cancer Center at the University of Alabama at Birmingham, Birmingham (C.A.L.); Oxford University Hospitals, Oxford, United Kingdom (S.N.); Washington University School of Medicine, St. Louis (A.R.H.); Kaiser Permanente Northern California, San Francisco (R.D.L., M.A.B.); and H.M. Hospitales-Centro Integral Oncológico H.M. Clara Campal, Madrid (J.G.-D.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1909707DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941439PMC
December 2019

Does Early Chemotherapy Improve Survival in Advanced Endometrial Cancer?

Am J Clin Oncol 2019 11;42(11):813-817

Department of Radiation Oncology, Huntsman Cancer Hospital.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0000000000000616DOI Listing
November 2019

Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial.

Lancet Oncol 2019 Oct 29;20(10):1409-1419. Epub 2019 Aug 29.

Nordic Society of Gynaecological Oncology, Copenhagen, Denmark; Department of Obstetrics and Gynecology and Tays Cancer Centre, Faculty of Medicine and Health Technology, Tampere University and University Hospital, Tampere, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(19)30515-7DOI Listing
October 2019

Recurrent early stage endometrial cancer: Patterns of recurrence and results of salvage therapy.

Gynecol Oncol 2019 07 24;154(1):38-44. Epub 2019 Apr 24.

Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2019.04.676DOI Listing
July 2019

Prognostic factors for rural endometrial cancer patients in a population-based cohort.

BMC Public Health 2019 Jul 10;19(1):921. Epub 2019 Jul 10.

Division of Public Health, Department of Family and Preventive Medicine, Huntsman Cancer Institute, University of Utah School of Medicine, 2000 Circle of Hope, Salt Lake City, UT, 84112, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12889-019-7262-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617574PMC
July 2019

Too many women are dying from cervix cancer: Problems and solutions.

Gynecol Oncol 2018 12 6;151(3):547-554. Epub 2018 Oct 6.

Huntsman Cancer Institute, 2000 Circle of Hope Drive, Salt Lake City, UT 84103, United States of America; Division of Oncology, Department of Medicine, University of Utah School of Medicine, 2000 Circle of Hope, Suite 2100, Salt Lake City, UT 84132, United States of America.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00908258183128
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2018.10.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281756PMC
December 2018

Long-term, adverse genitourinary outcomes among endometrial cancer survivors in a large, population-based cohort study.

Gynecol Oncol 2018 03 27;148(3):499-506. Epub 2017 Dec 27.

Division of Public Health, Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City, UT, United States; Huntsman Cancer Institute, Salt Lake City, UT, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2017.12.025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905702PMC
March 2018

A Phase I Study of Neoadjuvant Chemotherapy With Nab-Paclitaxel, Doxorubicin, and Cyclophosphamide in Patients With Stage II to III Breast Cancer.

Clin Breast Cancer 2017 11 29;17(7):503-509. Epub 2017 Apr 29.

Oncology Division, Department of Medicine, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT; Department of Surgery, University of South Alabama, Mitchell Cancer Institute, Mobile, AL; Department of Breast Oncology, Moffitt Cancer Center, Tampa, FL. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2017.04.010DOI Listing
November 2017

Nup153 and Nup50 promote recruitment of 53BP1 to DNA repair foci by antagonizing BRCA1-dependent events.

J Cell Sci 2017 Oct 27;130(19):3347-3359. Epub 2017 Jul 27.

Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1242/jcs.203513DOI Listing
October 2017

The Addition of Adjuvant Chemotherapy to Radiation in Early-Stage High-Risk Endometrial Cancer: Survival Outcomes and Patterns of Care.

Int J Gynecol Cancer 2017 06;27(5):912-922

*Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, Salt, Lake City, UT; †David Geffen School of Medicine at UCLA, Los Angeles, CA; and ‡Clinical Trials Office, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000963DOI Listing
June 2017

Corrigendum to "Chemoradiation versus chemotherapy or radiation alone in stage III endometrial cancer: Patterns of care and impact on overall survival" [Gynecol. Oncol. 141 (2016) 421-427].

Gynecol Oncol 2016 12 7;143(3):690-691. Epub 2016 Oct 7.

Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, Salt Lake City, UT, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2016.09.023DOI Listing
December 2016

Inconsistent Results With Different Secondary Reflex Assays for Resolving HER2 Status.

Am J Clin Pathol 2016 Nov;146(5):618-626

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ajcp/aqw177DOI Listing
November 2016

A phase I study to determine the pharmacokinetics and urinary excretion of belinostat and metabolites in patients with advanced solid tumors.

Cancer Chemother Pharmacol 2016 Nov 15;78(5):1059-1071. Epub 2016 Oct 15.

Huntsman Cancer Institute, The University of Utah, 2000 Circle of Hope, Ste 2123, Salt Lake City, UT, 84112, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-016-3167-7DOI Listing
November 2016

Genomic Copy Number Analysis of HER2-Equivocal Breast Cancers.

Am J Clin Pathol 2016 Oct 10;146(4):439-47. Epub 2016 Sep 10.

Department of Pathology, University of Utah, Salt Lake City.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ajcp/aqw130DOI Listing
October 2016

Chemoradiation versus chemotherapy or radiation alone in stage III endometrial cancer: Patterns of care and impact on overall survival.

Gynecol Oncol 2016 06 2;141(3):421-427. Epub 2016 Apr 2.

Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, Salt Lake City, UT, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2016.03.021DOI Listing
June 2016

A phase I clinical trial of the effect of belinostat on the pharmacokinetics and pharmacodynamics of warfarin.

Cancer Chemother Pharmacol 2016 Feb 30;77(2):299-308. Epub 2015 Dec 30.

Huntsman Cancer Institute, 2000 Circle of Hope, Salt Lake City, 84112, UT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-015-2934-1DOI Listing
February 2016

A pilot study of JI-101, an inhibitor of VEGFR-2, PDGFR-β, and EphB4 receptors, in combination with everolimus and as a single agent in an ovarian cancer expansion cohort.

Invest New Drugs 2015 Dec 14;33(6):1217-24. Epub 2015 Sep 14.

Department of Medicine, Oncology Division, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-015-0288-5DOI Listing
December 2015

Adenocarcinoma of the cervix: should we treat it differently?

Curr Oncol Rep 2015 Apr;17(4):17

Department of Radiation Oncology, Huntsman Cancer Institute-University of Utah, 1950 Circle of Hope, Room 1570, Salt Lake City, UT, 84112, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-015-0440-6DOI Listing
April 2015

Clinical performance of two multi-marker blood tests for predicting malignancy in women with an adnexal mass.

Clin Chim Acta 2015 Jan 2;438:358-63. Epub 2014 Oct 2.

Fujirebio Diagnostics, Inc., 201 Great Valley Parkway, Malvern, PA 19355, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cca.2014.09.028DOI Listing
January 2015

State of the science in cervical cancer: where we are today and where we need to go.

Cancer 2014 Aug 15;120(15):2282-8. Epub 2014 Apr 15.

Gillette Center for Gynecologic Oncology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts; Department of Medicine, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28722DOI Listing
August 2014

Ovarian cancer, version 2.2013.

J Natl Compr Canc Netw 2013 Oct;11(10):1199-209

From 1City of Hope Comprehensive Cancer Center; 2University of Alabama at Birmingham Comprehensive Cancer Center; 3The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; 4Fox Chase Cancer Center; 5UCSF Helen Diller Family Comprehensive Cancer Center; 6he Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; 7Vanderbilt-Ingram Cancer Center; 8The University of Texas MD Anderson Cancer Center; 9University of Washington/Seattle Cancer Care Alliance; 10Moffitt Cancer Center; 11Duke Cancer Institute; 12University of Michigan Comprehensive Cancer Center; 13Roswell Park Cancer Institute; 14Dana-Farber/Brigham and Women's Cancer Center; 15Massachusetts General Hospital Cancer Center; 16Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; 17Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; 18Memorial Sloan-Kettering Cancer Center; 19St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; 20Robert H. Lurie Comprehensive Cancer Center of Northwestern University; 21Stanford Cancer Institute; 22Huntsman Cancer Institute at the University of Utah; and 23National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2013.0142DOI Listing
October 2013

Significant evidence for a heritable contribution to cancer predisposition: a review of cancer familiality by site.

BMC Cancer 2012 Apr 3;12:138. Epub 2012 Apr 3.

Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-12-138DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350420PMC
April 2012

Locally recurrent endometrial cancer: a case report.

J Natl Compr Canc Netw 2012 Apr;10(4):442-5

Department of Medicine, Oncology Division, University of Utah Health Sciences Center and Huntsman Cancer Institute, Salt Lake City, Utah 84112, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2012.0045DOI Listing
April 2012

Current challenges in clinical management of endometrial cancer.

Adv Drug Deliv Rev 2009 Aug 5;61(10):883-9. Epub 2009 May 5.

Department Radiation Oncology, University of Utah Huntsman Cancer Hospital, Salt Lake City, UT 84112, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.addr.2009.04.014DOI Listing
August 2009

Familial myeloma.

N Engl J Med 2008 Oct;359(16):1734-5; author reply 1735

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc081677DOI Listing
October 2008

Management of cancer-associated thrombotic microangiopathy: what is the right approach?

Am J Hematol 2007 Apr;82(4):295-8

Division of Hematology, University of Utah Hospitals and Clinics, Salt Lake City, Utah, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.20783DOI Listing
April 2007

Acquired amegakaryocytic thrombocytopenic purpura.

Am J Hematol 2006 Feb;81(2):132-5

Division of Hematology, Department of Internal Medicine, University of Utah Health Sciences Center, Salt Lake City, Utah 84132, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.20510DOI Listing
February 2006